Abstract. The expression of neurofilament (NF) proteins was examined in the surgical specimen from a 42-year-old woman with Lhermitte-Duclos disease. Hypertrophic granule cell neurons of the dysplastic tissues were reactive with monoclonal antibodies, including antibodies to each of the three human NF subunits. Furthermore, antibodies to dephosphorylation-dependent epitopes on NF proteins stained the cell bodies of hypertrophic granule cells, whereas antibodies to phosphorylationdependent epitopes stained the enlarged and myelinated axons of the hypertrophic granule cells. Enzymatic dephosphorylation of this tissue abolished axonal staining with phosphorylation-dependent antibodies and uncovered determinants recognized by antibodies to the dephosphorylated state of NF proteins. The NF protein immunoreactivity of hypertrophic granule cells was indistinguishable from that oflarge, NF-rich neurons in control human cerebellum, suggesting that a normal pattern of expression and phosphorylation of NF proteins occurs in hypertrophic granule cells in Lhermitte-Duclos disease. An increased expression of NF proteins by cerebellar granule cells may account for many of the observed alterations of Lhermitte-Duclos disease, including the hypertrophy of the granule cells and enlargement of their axons, leading to the myelination of parallel fibers within the molecular layer of the cerebellum. Attention should now be directed at the underlying mechanisms which lead to the coordinated up-regulation of the three NF genes and whether or not additional gene products or cell types are altered in Lhermitte-Duclos disease.
INTRODUCTION
Lhermitte and Duclos (1) first described a malformation of circumscribed regions of the cerebellar cortex featuring enlarged and thickened folia containing abnormal ganglion cells. To date, 42 cases of Lhermitte-Duclos disease (dysplastic gangliocytoma ofthe cerebellum) have been reported in the literature; 13 ofthese, including the present report, have been surgical specimens (2, 3). While adults, ranging in age from 17 to 59 with a mean age of 34 years, are most commonly affected (2), the disease has been reported in a newborn (4). Patients usually come to clinical attention because of increased intracranial pressure secondary to obstructive hydrocephalus caused by obstruction of the aqueduct of Sylvius. Surgical resection has been the treatment of choice (3, 5, 6) .
The cellular changes in Lhermitte-Duclos disease have been well described in
